SCHEMBL2238868

SCHEMBL2238868

O=C(Cc1cc(F)cc(F)c1)Nc1cccc2nc(N[C@@H]3CCc4ccccc43)ccc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.40
TRPV1 Q8NER1 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GALR3 O60755 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
P2RX7 Q99572 6/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
ROCK2 O75116 2/20 0.38
ROCK1 Q13464 2/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
JAK3 P52333 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2243530 0.93 TRPV1 (0.45) TRPV1SMN1; SMN2GALR3HTTRAB9A
SCHEMBL2242730 0.92 ROCK2 (0.42) PARP1TRPV1SMN1; SMN2GALR3HTT
SCHEMBL2243238 0.87 ALDH1A1 (0.51) PARP1TRPV1SMN1; SMN2P2RX7KDM4E
SCHEMBL2243123 0.87 TRPV1 (0.45) TRPV1SMN1; SMN2GALR3HTTRAB9A
SCHEMBL1616171 0.86 TAS1R3 (0.42) PARP1TRPV1SMN1; SMN2RAB9AKDM4E
SCHEMBL2240751 0.85 MC4R (0.38) SMN1; SMN2GALR3HTTRAB9AP2RX7
SCHEMBL2242405 0.84 ALDH1A1 (0.53) SMN1; SMN2RAB9AP2RX7ALDH1A1
SCHEMBL1615636 0.84 NTRK1 (0.39) PARP1
SCHEMBL2243312 0.84 ALDH1A1 (0.48) TRPV1SMN1; SMN2GALR3HTTRAB9A
SCHEMBL2244825 0.82 KDM4E (0.44) PARP1TRPV1SMN1; SMN2HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994324-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US claimed
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US claimed
US-7994324-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US disclosed
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES HTR5A, HTR2C, HTR2B PARP1 735/4885TRPV1 486/4885SMN1; SMN2 1337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.